Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.
The funding will, in part, support efforts to expand the project's catalog of functional elements and understand their roles in different contexts.
The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.
The projects focus on early treatment of prostate cancer and cataloguing mutations in difficult-to-diagnose diseases, among other things.
The funding is part of the NHGRI Genome Technology Program, which promotes new methods, technology, and instruments for sequencing and functional genomics.
The technology uses DNAzyme-based sensors, fluorescent biomarkers, and a high-throughput particle counter to rapid identify rare targets in complex raw samples.
The scientists have adapted a technology first developed in fruit flies to spread malarial resistance genes in the Asian mosquito species A. stephensi.
Using funds from the California precision medicine initiative, the group will use its bioinformatics expertise to match patients to treatments in pediatric clinical trials.
An array of 15 HIV-1 recombinant protein and associated peptides matched very closely to ELISA results in evaluating the intricacies of associated antibody binding patterns.
By a GenomeWeb staff reporter
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.